Capmatinib has been used in trials studying the treatment of Melanoma, Gliosarcoma, Solid Tumors, Colorectal Cancer, and Hepatic Impairment, among others.Reference standards of Capmatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Capmatinib
Catalogue No.:PA 56 97000
CAS :
Molecular Formula : C23H17FN6O
Molecular Weight : 412.43
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
